Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

DE:NPAU Stock Latest News

Company AnnouncementsBetterLife Pharma Taps LifeSci Advisors as It Advances BETR-001 Toward 2027 Clinical Milestones6d ago

Company AnnouncementsBetterLife Pharma Strengthens Headache Program with New Scientific Advisory Co-Chair2w ago
Company AnnouncementsBetterLife Pharma Taps Clinical Veteran to Lead BETR-001 First-in-Human Study2w ago
Company AnnouncementsBetterLife Pharma Taps Migraine Pioneer to Lead BETR-001 Headache Program2w ago
Company AnnouncementsBetterLife Pharma Faces Legal Dispute With Director Over Convertible Debenture3w ago

BetterLife Pharma Resets Shareholder Meeting to Advance Nasdaq Listing Plans

Company AnnouncementsBetterLife Pharma Resets Shareholder Meeting to Advance Nasdaq Listing Plans1M ago

Company AnnouncementsBetterLife Pharma Raises US$100 Million to Advance Neurological Drug BETR-0011M ago

Company AnnouncementsBetterLife Pharma Taps Veteran Biotech Strategist Charles Duncan to Lead Audit Committee2M ago

Company AnnouncementsBetterLife Pharma Prices US$100 Million Equity Offering to Advance Neurology Trials2M ago
The FlyPsychedelic: SciSparc, Clearmind publish patent application for PTSD treatment2M agoCMND IXHL
Company AnnouncementsBetterLife Pharma Plans Equity Offering to Advance Neurological Trial Program2M ago
Company AnnouncementsBetterLife Pharma Names Veteran Migraine Specialist as CMO to Drive BETR-001 Development2M ago

BetterLife Pharma Issues Shares and Extends Convertible Debenture Maturities

Company AnnouncementsBetterLife Pharma Issues Shares and Extends Convertible Debenture Maturities6M ago

Company AnnouncementsBetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug6M ago

Company AnnouncementsBetterLife Pharma Grants 6.05 Million Stock Options to Insiders8M ago

Company AnnouncementsBetterLife Pharma Targets Global Partners for BETR-001 at JPM Week Forums9M ago
Company AnnouncementsBetterLife Pharma Director and Audit Chair Robert Metcalfe Resigns10M ago
Company AnnouncementsBetterLife Pharma Partners with YAFO Capital for BETR-001 Expansion in Greater China10M ago
Company AnnouncementsBetterLife Pharma Advances BETR-001 as a Non-Hallucinogenic Neuroplastogen11M ago

BetterLife Pharma Appoints Daniel Carcillo as Corporate Advisor

Company AnnouncementsBetterLife Pharma Appoints Daniel Carcillo as Corporate Advisor11M ago

Company AnnouncementsBetterLife Pharma Announces Debt Conversion and Board Resignation11M ago

Company AnnouncementsBetterLife Pharma Appoints Doug Drysdale as Corporate Advisor to Advance Neurological Treatments1y ago